TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.

Youn H Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.